MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Augusta, Evans +2367 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Clinical Trials at Augusta University Medical Center
As of August 2026, 40 paid clinical trials are recruiting at Augusta University Medical Center, located at 1120 15TH ST, AUGUSTA, GA 30912-0004, phone (706) 721-6597 in Augusta, Georgia. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Ovarian Cancer and Sickle Cell Disease. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
40 clinical trials at Augusta University Medical Center
·Clear filters· Get a weekly email when new trials open in Augusta, GA.
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
for Relapsed Non-Hodgkin Lymphoma
Sites in Augusta +31 more locations
Sponsor: Lyell Immunopharma, Inc.
Sex: All·Age: 18+
Code: NCT05826535·Phase 1, Phase 2·Recruiting·Listed Apr 2023
Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis
for AAA - Abdominal Aortic Aneurysm
Sites in Augusta, Decatur +54 more locations
Sponsor: W.L.Gore & Associates
Sex: All·Age: 18+
Code: NCT06218875·Recruiting·Listed Jan 2024
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.
for Candidemia
Sites in Augusta, Atlanta +20 more locations
Sponsor: Basilea Pharmaceutica
Sex: All·Age: 18+
Code: NCT05421858·Phase 3·Recruiting·Listed Jun 2022
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
for Invasive Mould Infection
Sites in Augusta +6 more locations
Sponsor: Elion Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07215273·Phase 2·Recruiting·Listed Oct 2025
Visugromab in Cachexia International Trial
for Cancer-associated Cachexia
Sites in Augusta +9 more locations
Sponsor: CatalYm GmbH
Sex: All·Age: 18+
Code: NCT07112196·Phase 2, Phase 3·Recruiting·Listed Aug 2025
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
for Advanced Endometrial Carcinoma
Drug: Bevacizumab
Sites in Augusta, Decatur +254 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT07198074·Phase 3·Recruiting·Listed Sep 2025
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
for Miscellaneous Neoplasm, Nos
Sites in Augusta +277 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07091617·Recruiting·Listed Jul 2025
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for Fallopian Tube Endometrioid Adenocarcinoma
Drug: Bevacizumab
Sites in Augusta, Decatur +653 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT06580314·Phase 3·Recruiting·Listed Aug 2024
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
for Adenocarcinoma of the Colon
Sites in Augusta, Savannah +325 more locations
Sponsor: NRG Oncology
Sex: All·Age: 45 - 70
Code: NCT05080673·Recruiting·Listed Oct 2021
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for Childhood Extracranial Germ Cell Tumor
Sites in Augusta, Macon +380 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: All ages
Code: NCT03067181·Phase 3·Recruiting·Listed Mar 2017
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
for Locally Advanced Lung Non-Small Cell Carcinoma
Sites in Augusta, Savannah +444 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+
Code: NCT05624996·Phase 3·Recruiting·Listed Nov 2022
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for B Acute Lymphoblastic Leukemia
Sites in Augusta, Atlanta +153 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18 - 39
Code: NCT03150693·Phase 3·Recruiting·Listed May 2017
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for Acute Myeloid Leukemia
Sites in Augusta, Albany +328 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT05564390·Phase 2·Recruiting·Listed Oct 2022
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
for Mantle Cell Lymphoma
Sites in Augusta, Johns Creek +228 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 60+
Code: NCT05976763·Phase 3·Recruiting·Listed Aug 2023
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
for Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Drug: Nivolumab
Sites in Augusta, Macon +378 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 5 - 60
Code: NCT05675410·Phase 3·Recruiting·Listed Jan 2023
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
for Classic Follicular Lymphoma
Drug: Mosunetuzumab
Sites in Augusta, Atlanta +251 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06337318·Phase 3·Recruiting·Listed Mar 2024
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for Acute Myeloid Leukemia
Sites in Augusta, Albany +204 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18 - 59
Code: NCT05554406·Phase 2·Recruiting·Listed Sep 2022
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
for Acute Myeloid Leukemia
Drug: Venetoclax
Sites in Augusta, Albany +214 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06317649·Phase 2·Recruiting·Listed Mar 2024
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
for Acute Myeloid Leukemia
Sites in Augusta +128 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT06672146·Phase 2·Recruiting·Listed Nov 2024
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
for Endometrial Adenocarcinoma
Drug: Ipilimumab
Sites in Augusta +124 more locations
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18+
Code: NCT05112601·Phase 2·Recruiting·Listed Nov 2021
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for B Acute Lymphoblastic Leukemia
Sites in Augusta, Macon +185 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: 365 Days - 25
Code: NCT03959085·Phase 3·Recruiting·Listed May 2019
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for Acute Myeloid Leukemia
Sites in Augusta, Savannah +167 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 21
Code: NCT04293562·Phase 3·Recruiting·Listed Mar 2020
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
for B Acute Lymphoblastic Leukemia
Sites in Augusta, Macon +136 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 366 Days - 46
Code: NCT06124157·Phase 2·Recruiting·Listed Nov 2023
Project: Every Child for Younger Patients With Cancer
for Adrenal Gland Pheochromocytoma
Sites in Augusta, Macon +225 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 25
Code: NCT02402244·Recruiting·Listed Mar 2015
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
for Stage I Mixed Cell Type Kidney Wilms Tumor
Sites in Augusta, Macon +151 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 30
Code: NCT06401330·Phase 3·Recruiting·Listed May 2024
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
for Anaplastic Kidney Wilms Tumor
Sites in Augusta, Macon +170 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: Up to 30
Code: NCT04322318·Phase 2·Recruiting·Listed Mar 2020
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
for B Acute Lymphoblastic Leukemia Associated With Down Syndrome
Sites in Augusta, Atlanta +70 more locations
Sponsor: Children's Oncology Group
Sex: All·Age: 6 - 39
Code: NCT05702645·Recruiting·Listed Jan 2023
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
for Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Sites in Augusta +40 more locations
Sponsor: NRG Oncology
Sex: Female·Age: 18+
Code: NCT05646316·Phase 3·Recruiting·Listed Dec 2022
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
for Malignant Solid Neoplasm
Sites in Augusta, Savannah +586 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+
Code: NCT04871542·Recruiting·Listed May 2021
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
for Hematopoietic and Lymphatic System Neoplasm
Sites in Augusta +27 more locations
Sponsor: NRG Oncology
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT06279013·Recruiting·Listed Feb 2024
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
for Malignant Digestive System Neoplasm
Sites in Augusta, Lawrenceville +56 more locations
Sponsor: Wake Forest University Health Sciences
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07215624·Recruiting·Listed Oct 2025
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
for Intracerebral Hemorrhage
Sites in Augusta, Atlanta +140 more locations
Sponsor: Yale University
Sex: All·Age: 18+
Code: NCT03907046·Phase 3·Recruiting·Listed Apr 2019
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
for Colorectal Cancer Stage II
Sites in Augusta, Savannah +373 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 18+·Accepts healthy volunteers
Code: NCT07018869·Phase 3·Recruiting·Listed Jun 2025
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
for Castration Levels of Testosterone
Sites in Augusta, Decatur +292 more locations
Sponsor: SWOG Cancer Research Network
Sex: Male·Age: 18+
Code: NCT03678025·Phase 3·Recruiting·Listed Sep 2018
Defecation Patterns in Constipated Patients
for Constipation by Outlet Obstruction
1 location in Augusta
Sponsor: The California Medical Innovations Institute, Inc.
Sex: All·Age: 21 - 75·Accepts healthy volunteers
Code: NCT04903470·Recruiting·Listed May 2021
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
for Normal Subjects
1 location in Augusta
Sponsor: The California Medical Innovations Institute, Inc.
Sex: All·Age: 18 - 75·Accepts healthy volunteers
Code: NCT05412069·Recruiting·Listed Jun 2022
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
for Hematopoietic and Lymphatic System Neoplasm
Sites in Augusta +21 more locations
Sponsor: National Cancer Institute LAO
Sex: All·Age: 2 Months+
Code: NCT02474160·Recruiting·Listed Jun 2015
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
for Recurrent T Acute Lymphoblastic Leukemia
Sites in Augusta, Atlanta +112 more locations
Sponsor: SWOG Cancer Research Network
Sex: All·Age: 12+
Code: NCT04315324·Phase 1, Phase 2·Recruiting·Listed Mar 2020
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for Angioimmunoblastic T-cell Lymphoma
Sites in Augusta, Atlanta +84 more locations
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All·Age: 18+
Code: NCT04803201·Phase 2·Recruiting·Listed Mar 2021
Common conditions studied in Augusta
- Acute Myeloid Leukemia (7 active studies)
- Ovarian Cancer (6 active studies)
- Sickle Cell Disease (5 active studies)
- Cervical Cancer (4 active studies)
- Endometrial Cancer (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
Leading research sponsors in Augusta
- Augusta University
- National Cancer Institute (NCI)
- Children's Oncology Group
- NRG Oncology
- SWOG Cancer Research Network
Frequently asked questions
How many paid clinical trials are currently recruiting in Augusta?
There are approximately 176 recruiting clinical trials in Augusta, Georgia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Augusta pay participants?
Most recruiting trials in Augusta compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Augusta?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Augusta?
The most common conditions under active study in Augusta include Acute Myeloid Leukemia (7), Ovarian Cancer (6), Sickle Cell Disease (5), Cervical Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Augusta?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Augusta on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Augusta?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Augusta?
Recruiting research sites in Augusta include Augusta University Medical Center, Augusta University, Georgia Cancer Center at Augusta University, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Augusta right now?
The largest active categories in Augusta are Cancer & tumors (66), Neurology & pain (11), Eye & vision (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Augusta University Medical Center?
Augusta University Medical Center is located at 1120 15TH ST, AUGUSTA, GA 30912-0004. Use the Google Maps link in the intro above to get directions.
How do I contact Augusta University Medical Center?
You can reach Augusta University Medical Center by phone at (706) 721-6597. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Georgia
Atlanta, GA(1,472)Decatur, GA(182)Savannah, GA(131)Marietta, GA(93)Macon, GA(70)Columbus, GA(64)Lawrenceville, GA(59)Athens, GA(55)Newnan, GA(52)Gainesville, GA(49)Johns Creek, GA(35)Stockbridge, GA(32)Snellville, GA(26)Fayetteville, GA(22)Sandy Springs, GA(22)Woodstock, GA(22)Union City, GA(19)Albany, GA(17)Canton, GA(16)Brunswick, GA(15)Duluth, GA(15)Roswell, GA(15)Tucker, GA(14)Thomasville, GA(13)Conyers, GA(12)Norcross, GA(12)Cordele, GA(11)Cumming, GA(11)Douglasville, GA(11)East Point, GA(11)Peachtree Corners, GA(11)Hinesville, GA(10)Suwanee, GA(10)Alpharetta, GA(9)Dalton, GA(9)Stone Mountain, GA(9)Austell, GA(8)Riverdale, GA(8)Valdosta, GA(8)Braselton, GA(7)Rincon, GA(7)Dunwoody, GA(6)Morrow, GA(6)Smyrna, GA(6)Tifton, GA(6)Acworth, GA(5)Cartersville, GA(5)Lilburn, GA(5)Buford, GA(4)Carrollton, GA(4)Dublin, GA(4)Jasper, GA(4)Kennesaw, GA(4)Peachtree City, GA(4)Ringgold, GA(4)Rome, GA(4)Warner Robins, GA(4)Adairsville, GA(3)College Park, GA(3)Dawsonville, GA(3)